Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More
Trade Brains
OCTOBER 6, 2023
It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. As per IQVIA report, the global medicine market is expected to reach USD 1.9 In its pursuit of creating depth in anti-diabetics, the Company signed a perpetual license agreement with Novartis for Vildagliptin and its combination brands.
Let's personalize your content